Rhythm Pharmaceuticals, Inc. (RYTM)
87.86
+1.94
(+2.25%)
USD |
NASDAQ |
Jun 09, 16:00
87.89
+0.03
(+0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals EPS Diluted (Quarterly) : -0.8348 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Biogen, Inc. | 2.153 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| AbbVie, Inc. | 0.3861 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.64M |
| Revenue (Quarterly) | 60.11M |
| Total Expenses (Quarterly) | 115.75M |
| Enterprise Value | 5.900B |
| Gross Profit Margin (Quarterly) | 88.01% |
| Profit Margin (Quarterly) | -92.56% |
| Earnings Yield | -3.57% |
| Normalized Earnings Yield | -3.557 |